Psychology Wiki


34,203pages on
this wiki
Add New Page
Talk0 Share

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

Methysergide chemical structure

1-Methyl-d-lysergic acid-(1-hydroxybut-2-yl)amide
IUPAC name
CAS number
ATC code


Chemical formula {{{chemical_formula}}}
Molecular weight 353.458 g/mol
Elimination half-life
Excretion {{{excretion}}}
Pregnancy category X
Legal status
Routes of administration

Main article: Serotonin antagonists

Methysergide (UML-491) is a prescription drug used for prophylaxis of migraine headaches and is sold under the brand names Sansert and Deseril in 2mg dosages.


It is a receptor antagonist for the 5-HT receptor 2C[1]. It also is a 5-HT1A receptor antagonist.[2]

It is known to have partial agonists effects on 5-HT receptors as well.[3]


Methysergide is one of the most effective[4] medications for the prevention of migraine, but not for the treatment of an acute attack.

Side effectsEdit

It has a known side effect, retroperitoneal fibrosis[5], which is severe, although uncommon.

In addition, there is an increased risk of left-sided cardiac valve dysfunction.[4][6]


Methysergide was approved by the FDA in 1962.

Novartis withdrew it from the U.S. market after taking over Sandoz, but currently lists it as a product.

Related compoundsEdit

Its molecular structure is closely related to that of LSD.

Like LSD, methysergide also produces psychedelic and hallucinogenic effects above a dosage of about 4mg.[7] Full effects are felt with dosages of 8-20mg.[How to reference and link to summary or text]

About 4 mg is equal to 25mcg of LSD.[8]

See alsoEdit



  1. Rang, H. P. (2003). Pharmacology, Edinburgh: Churchill Livingstone. Page 187
  2. Saxena PR, Lawang A (October 1985). A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. Arch Int Pharmacodyn Ther 277 (2): 235–52.
  3. Colpaert FC, Niemegeers CJ, Janssen PA (October 1979). In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists. Eur. J. Pharmacol. 58 (4): 505–9.
  4. 4.0 4.1 Joseph T, Tam SK, Kamat BR, Mangion JR (2003). Successful repair of aortic and mitral incompetence induced by methylsergide maleate: confirmation by intraoperative transesophageal echocardiography. Echocardiography 20 (3): 283–7.
  5. (2002)
  6. 1997 Mayo Clinic study linking heart disease to Fen Phen Valvular heart disease associated with fenfluramine-phentermine
  7. L. Bender (1970): "Children's Reactions to Psychotomimetic Drugs", Psychotomimetic Drugs, pp. 265-273]
  8. Abramson HA, Rolo A (September 1965). Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects. J Asthma Res 3 (1): 81–96.

External linksEdit

Template:Serotonin antagonists

Template:Antimigraine preparations

This page uses Creative Commons Licensed content from Wikipedia (view authors).

Ad blocker interference detected!

Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers

Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.

Also on Fandom

Random Wiki